Here, we describe the first cases of an MPS‐like disease caused by an intronic variant in VPS16. We identified two unrelated individuals presenting with a clinical phenotype characterized by global developmental regression, facial dysmorphism, delayed myelination, skeletal abnormalities (dysostosis multiplex), and recurrent anemia and neutropenia. Here, VPS16 is linked to neutropenia.